Improving clinical trials in the critically ill

Critical Care Medicine

Volumn 38, Issue 2, 2010, Pages 527-532

  Angus, Derek C ^a,b   Mira, Jean Paul ^c   Vincent, Jean Louis ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d ERASME HOSPITAL   (Belgium)

Author keywords

Intensive care; New technologies

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; HEALTH CARE QUALITY; HUMAN; INTENSIVE CARE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 74949085894     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181c0259d     Document Type: Article

References (29)

1. Ospina-Tascon G, Luiz Buchele G, Vincent JL: Multicenter randomized controlled trials evaluating mortality in intensive care: Doomed to fail? Crit Care Med 2008 36 1311-1322
2. Perel P, Roberts I, Sena E, et al: Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 2007; 334:197
3. Checchia PA, Schierding W, Polpitiya A, et al: Myocardial transcriptional profiles in a mu-rine model of sepsis: Evidence for the importance of age. Pediatr Crit Care Med 2008; 9:530-535
4. Lutterloh EC, Opal SM, Pittman DD, et al: Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit Care 2007; 11:R122
5. Renckens R, van Westerloo DJ, Roelofs JJ, et al: Acute phase response impairs host defense against Pseudomonas aeruginosa pneumonia in mice. Crit Care Med 2008; 36: 580-587
6. Celik I, Stinner B, Lorenz W, et al: [Reduction of cardiovascular disorders by preventive perioperative antihistamine administration in general surgery: Are the drugs interchangeable?]. Langenbecks Arch Chir Suppl Kongressbd 1998; 115:731-735
7. Kircher MF, Grimm J, Swirski FK, et al: Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions. Circulation 2008; 117:388-395
8. Calvano SE, Xiao W, Richards DR, et al: A network-based analysis of systemic inflammation in humans. Nature 2005; 437: 1032-1037
9. Vodovotz Y, Clermont G, Hunt CA, et al: Evidence-based modeling of critical illness: an initial consensus from the Society for Complexity in Acute Illness. J Crit Care 2007; 22:77-84
10. Goh KI, Cusick ME, Valle D, et al: The human disease network. Proc Natl Acad Sci USA 2007; 104:8685-8690
11. Clermont G, Bartels J, Kumar R, et al: In silico design of clinical trials: A method coming of age. Crit Care Med 2004; 32: 2061-2070
12. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 2004; 363:600-607
13. Christ-Crain M, Stolz D, Bingisser R, et al: Procalcitonin-guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med 2006; 174:84-93
14. Nobre V, Harbarth S, Graf JD, et al: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: A randomized trial. Am J Respir Crit Care Med 2008; 177: 498-505
15. Caffrey SL, Willoughby PJ, Pepe PE, et al: Public use of automated external defibrilla-tors. N Engl J Med 2002; 347:1242-1247
16. Hillman K, Chen J, Cretikos M, et al: Introduction of the medical emergency team (MET) system: A cluster-randomised controlled trial. Lancet 2005; 365:2091-2097
17. Delaney A, Angus DC, Bellomo R, et al: Bench-to-bedside review: The evaluation of complex interventions in critical care. Crit Care 2008; 12:210
18. Chiche JD, Angus DC: Testing protocols in the intensive care unit: Complex trials of complex interventions for complex patients. JAMA 2008; 299:693-695
19. Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340:409-417
20. Deans KJ, Minneci PC, Suffredini AF, et al: Randomization in clinical trials of titrated therapies: Unintended consequences of using fixed treatment protocols. Crit Care Med 2007; 35:1509-1516
21. Macias WL, Vallet B, Bernard GR, et al: Sources of variability on the estimate of treatment effect in the PROWESS trial: Implications for the design and conduct of future studies in severe sepsis. Crit Care Med 2004; 32:2385-2391
22. Zelen M: A new design for randomized clinical trials. N Engl J Med 1979; 300: 1242-1245
23. Curtis JR, Engelberg RA, Wenrich MD, et al: Studying communication about end-of-life care during the ICU family conference: development of a framework. J Crit Care 2002; 17:147-160
24. Lautrette A, Darmon M, Megarbane B, et al: A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med 2007; 356:469-478
25. Cook D, Guyatt G, Marshall J, et al: A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998; 338:791-797
26. Bellomo R, Chapman M, Finfer S, et al: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356:2139-2143
27. Sandham JD, Hull RD, Brant RF, et al: A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348:5-14
28. Finfer S, Bellomo R, Boyce N, et al: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256 (Pubitemid 38669207)
29. Vincent JL, Sakr Y, Sprung CL, et al: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34: 344-353